Abstract
Transforming growth factor β (TGF‐β) and interleukin 2 may be involved in IBD peripheral regulatory T cell pathophysiology, raising the possibility of therapeutic application of TGF‐β induced regulatory T cells in IBD patients
MeSH terms
-
Colitis / immunology*
-
Humans
-
Immunosuppression Therapy
-
Interleukin-2 / immunology
-
T-Lymphocytes, Regulatory / immunology*
-
Thymus Gland / immunology
-
Transforming Growth Factor beta / immunology*
Substances
-
Interleukin-2
-
Transforming Growth Factor beta